Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
In this photo made with a long exposure, a man is silhouetted against lights reflected in the waters…
Read MorePsychedelic
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
Clearmind Medicine Inc. Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.…
Read More